Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05454280 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 1 entry Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 526 participants (planned 880)
    • Eligibility criteria expanded, about 16 words
    • Site details revised
    • Study description expanded, about 3 words
  2. Trial status: Suspended to Recruiting
    • Site details revised
    v7
  3. Trial status: Recruiting to Suspended Sponsor's reason: Pending interim analysis
    • Site details revised
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2022 to Oct 14, 2022
    • Site details revised
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Sep 1, 2022 to Nov 1, 2022v3
  2. Study title shortened, about 5 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).
Trial Details
NCT Number NCT05454280
Lead Sponsor Fox Chase Cancer Center
Conditions
(from sponsor)		 Surgery, Cancer
Related terms Neoplasms
Enrollment 526 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov